Faculty

Alexis Ogdie, MD, MSCE

Associate Professor of Medicine (Rheumatology) at the Hospital of the University of Pennsylvania

Department: Medicine

Graduate Group Affiliations

Graduate Group in Epidemiology and Biostatistics

Contact information

3400 Spruce Street
5 White Building
Hospital of the University of Pennsylvania
Philadelphia, PA 19104-4283

Office: 215-662-2454
Fax: 215-662-4500

Education:
BS
University of Minnesota, 2002.
MD
Georgetown University School of Medicine, 2006.
MSCE
University of Pennsylvania, 2012.

Permanent link

> Perelman School of Medicine > Faculty > Details

Description of Clinical Expertise

Psoriatic Arthritis, Ankylosing Spondylitis, Spondyloarthropathies, Other Inflammatory Arthritis (e.g. Rheumatoid Arthritis)

Description of Research Expertise

Psoriatic Arthritis, Axial Spondyloarthritis, Epidemiology, Pharmacoepidemiology

Selected Publications

Allenzara A, Bush K, Husni ME, Reddy SM, Scher JU, Craig E, Koplin J, Walsh JA, Ogdie A.: Diverse Treatment Goals in Psoriatic Arthritis: Insights from participants in the PARC cohort. Arthritis Care Res (Hoboken) Mar 2025.

Ogdie A, Reddy SM, Gillespie SH, Husni ME, Scher JU, Salomon-Escoto K, Kay J, Luedders BA, Curtis JR, Shields AJS, Chakravarty SD, Gong C, Walsh JA.: Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial. Trials 26: 96, Mar 2025.

Perez-Chada LM, Gondo G, Grant C, Woodbury M, Kucharik AH, Armstrong AW, Eder L, Mease P, Ogdie A, Strand V, Gottlieb AB, Merola JF.: Construct validity of the IDEOM MSK Questionnaire (IDEOM MSK-Q): an instrument to measure musculoskeletal symptoms in patients with psoriatic disease. J Invest Dermatol Jan 2025.

Karmacharya P, Crofford LJ, Byrne DW, Stephens-Shields A, Husni ME, Scher JU, Craig E, Fitzsimmons R, Reddy SM, Magrey MN, Walsh JA, Ogdie A.: Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium. Ann Rheum Dis 2025.

Song WB, Michaud K, Lonowski SL, Kaufmann M, Pearson R, Del Rosso JQ, Schumacher R, Ogdie AR, Gelfand JM.: The FORWARD Psoriasis Registry: Patient-Reported Outcomes in a Novel Psoriasis Registry and Comparison of Traditional, Dermatologist-Led Enrollment With Web-Based Patient Enrollment. J Psoriasis Psoriatic Arthritis Nov 2024.

Kristensen LE, Tillett W, Nash P, Coates LC, Mease PJ, Ogdie A, Gisondi P, Ink B, Prickett AR, Bajracharya R, Taieb V, Lyris N, Lambert J, Walsh JA.: Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies. Ther Adv Musculoskelet Dis 16: 1759720X241288071, Nov 2024.

Gillcrist RL, Doherty CR, Olave M, Bonilla J, England BR, Wysham K, Quinones M, Scanzello CR, Ogdie A, White DK, Neogi T, Baker JF.: A Remote Behaviorally Designed Intervention to Promote Physical Activity in Patients With Knee Osteoarthritis: Results of a Pilot Randomized Clinical Trial. J Clin Rheumatol 30: 336-339, Oct 2024.

Ogdie A, Kristensen LE, Soriano ER, Akar S, Sun Y, Gruben D, Fallon L, Kinch CD, Gladman DD.: Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status. Rheumatol Ther Sep 2024.

Liew JW, Pedro S, Michaud K, Ogdie A.: Opioid Use and Healthcare Utilization in Adults With Psoriatic Arthritis and Ankylosing Spondylitis. J Rheumatol 51: 1009-1014, Aug 2024.

Wright GC, Mysler E, Kwok K, Cadatal MJ, Germino R, Yndestad A, Kinch CD, Ogdie A.: Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials. Rheumatol Ther Jul 2024.